Bayer | BAYN - Gross Profit On Sales


Bayer reported EUR6.94B in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Air Liquide EUR 8.65B 4.44B Dec/2024
Akzo Nobel EUR 936M 102M Dec/2025
Alcon AG USD 1.69B 175M Mar/2026
Amarin USD 23.17M 961K Dec/2025
Arkema EUR 455M 14M Jun/2025
AstraZeneca USD 12.61B 225M Mar/2026
BASF EUR 3.11B 55M Dec/2025
Bayer EUR 6.94B 1.58B Dec/2025
Beiersdorf EUR 1.54B 1.16B Jun/2025
Corteva USD 2.37B 876M Mar/2026
Covestro EUR 212M 276M Dec/2025
Essilor EUR 8.3B 547M Dec/2025
Fresenius EUR 1.51B 214M Dec/2025
Fresenius Medical Care EUR 1.18B 210M Mar/2026
Genmab DKK 977M 13M Dec/2025
Givaudan CHF 1.55B 140M Dec/2025
GlaxoSmithKline GBP 5.75B 429M Mar/2026
GRIFOLS EUR 686.84M 56.95M Dec/2025
Hikma Pharmaceutical USD 362.5M 329.5M Jun/2025
Johnson Matthey GBP 480M 33M Jun/2024
Linde USD 3.27B 969M Dec/2025
Lonza CHF 1.29B 248M Jun/2025
Merck EUR 3.07B 104M Mar/2026
Novartis USD 10.07B 184M Mar/2026
Nutrien USD 1.65B 242M Mar/2026
Philips EUR 1.77B 522M Mar/2026
PPG Industries USD 1.46B 54M Dec/2025
Roche Holding CHF 22.09B 10.04B Dec/2025
Sanofi EUR 8.45B 1.31B Dec/2025
SAP EUR 6.97B 149M Mar/2026
Solvay EUR 266M 31M Mar/2026
UCB EUR 3.19B 621M Dec/2025
Umicore EUR 308.6M 10.45M Dec/2024
Vinci EUR 2.44B 27.34B Jun/2025